TITLE

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease

AUTHOR(S)
Wolfe, N; Katz, D I; Albert, M L; Almozlino, A; Durso, R; Smith, M C; Volicer, L
PUB. DATE
October 1990
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct1990, Vol. 53 Issue 10, p915
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66107241

 

Related Articles

  • Emotional dysfunction in Parkinson's disease. Blonder, Lee X.; Slevin, John T. // Behavioural Neurology;2011, Vol. 24 Issue 3, p201 

    In addition to motor symptomatology, idiopathic Parkinson's disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional...

  • Parkinson's Disease Linked to Low Vitamin D.  // Environmental Nutrition;Dec2008, Vol. 31 Issue 12, p1 

    The article reports on the findings of the study by researchers from Emory University in Atlanta, Georgia regarding the role of vitamin D in Parkinsonism. The research found 55% of patients with Parkinson's disease had low levels of vitamin D compared to 41% of those with Alzheimer's disease....

  • Parkinson's disease linked with pesticide. Berger, Abi // BMJ: British Medical Journal (International Edition);11/11/2000, Vol. 321 Issue 7270, p1175 

    Reports on the results of a study linking the organic pesticide rotenone with Parkinson's disease. Details of the pathogenesis of the disease; Suggestion that pesticides may be responsible for the degeneration of neurons containing dopamine; Overview of animal research models involving...

  • Calendar.  // Current Medical Literature: Neurology;2003, Vol. 19 Issue 3, p73 

    Presents several congresses on neurology from February to May 2004. International Neuropsychological Society Annual Meeting; International Conference on Alzheimer's Disease and Parkinson's Disease; Annual Meeting of the American Academy of Neurology.

  • Pergolide Off the Market, Heart Disease Risk. Elliott, William T. // Internal Medicine Alert;5/15/2007, Vol. 29 Issue 9, p2 

    The article reports on the withdrawal of pergolide, a dopamine agonist used for the treatment of Parkinson's disease, from the market after reports of serious valvular heart disease linked with the drug.

  • Battling Brain Diseases: Diet Links To Alzheimer's And Parkinson's. Antinoro, Linda // Environmental Nutrition;Apr2001, Vol. 24 Issue 4, p1 

    Focuses on the link of nutrition to Alzheimer's and Parkinson's diseases. Symptoms of the diseases; Contribution of antioxidants to the degeneration of brain and nerve cells; List of possible protectors and promoters of the diseases.

  • The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Cummings, Jeffrey L.; Henchcliffe, Claire; Schaier, Sharon; Simuni, Tanya; Waxman, Alan; Kemp, Paul // Brain: A Journal of Neurology;Nov2011, Vol. 134 Issue 11, p3146 

    Diagnosis of neurological and psychiatric conditions associated with disturbances of dopaminergic functioning can be challenging, especially in the early stages, and may be assisted with biomarkers such as dopamine system imaging. Distinguishing between Alzheimer’s disease and dementia...

  • COMPANY SPOTLIGHT - H Lundbeck.  // PharmaWatch: CNS;Nov2007, Vol. 6 Issue 11, p12 

    The article focuses on the company profile of H LundbeckA/S, a pharmaceutical company that focuses on the treatment of diseases of the central nervous system (CNS). The company's approved drugs include Cipralex/Lexapro for the treatment of depression and anxiety, Ebixa for Alzheimer's disease,...

  • FURTHER READING.  // PharmaWatch: CNS;Mar2011, Vol. 10 Issue 3, p30 

    The article offers information on the reports on various diseases, such as neuropathic pain, Parkinson's disease, and major depressive disorder, and PharmaVitae profiles for various pharmaceutical industries in 2010-2011.

  • Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys.  // Psychopharmacology;Nov2006, Vol. 188 Issue 4, p586 

    The article discusses a study on the role of dopamine receptor subtypes in complex functions of the brain. It was found that spatial working memory and visuo-spatial associative memory were both impacted by dopamine. This knowledge can be useful in treating mental health disorders such as...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics